Octave Bioscience Gets $10 Mln Grant from Michael J. Fox Foundation for Parkinson’s
By Healthcare Edge Editorial Staff Octave Bioscience, Inc., a company offering treatment for multiple sclerosis and other neurodegenerative diseases, said it has received a $10 million grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF). The...